Min Hyuk Choi , Dokyun Kim , Jihyun Kim , Young Goo Song , Seok Hoon Jeong
{"title":"按血流感染时间段划分的死亡风险因素的变化","authors":"Min Hyuk Choi , Dokyun Kim , Jihyun Kim , Young Goo Song , Seok Hoon Jeong","doi":"10.1016/j.jmii.2023.11.008","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>This study was designed to determine changes in risk factors on the prognosis of patients during each period of the bloodstream infection (BSI) timeline.</p></div><div><h3>Methods</h3><p>Through an integrated study of multivariable regressions with machine learning techniques, the risk factors for mortality during each period of BSI were analyzed.</p></div><div><h3>Results</h3><p>A total of 302,303 inpatients who underwent blood cultures during 2011–2021 were enrolled. More than 8 % of BSI cases progressed to subsequent BSI, and risk factors were identified as gut colonization with vancomycin-resistant enterococci (aOR 1.82; 95 % CI 1.47–2.24), intensive care unit admission (aOR 3.37; 95 % CI 3.35–4.28), and current cancer chemotherapy (aOR 1.54; 95 % CI 1.36–1.74). The mean SOFA score of the deceased patients during the first 7 days was 10.6 (SD 4.3), which was significantly higher than those on days 8–30 (7.0 ± 4.2) and after Day 30 (4.0 ± 3.5). BSIs caused by <em>Acinetobacter baumannii</em> and <em>Candida albicans</em> were more likely to result in deaths of patients for all time periods (all, <em>P</em> < 0.001). BSIs caused by <em>Enterococcus faecalis</em> and <em>Enterococcus faecium</em> were associated with a poor outcome in the period after Day 30 (both, <em>P</em> < 0.001). Nonsusceptible phenotypes to β-lactam/β-lactamase inhibitors of <em>Escherichia coli</em> and <em>Klebsiella pneumoniae</em> influenced the prognoses of patients with BSI in terms of high mortality rates during both days 8–30 and after Day 30.</p></div><div><h3>Conclusion</h3><p>Influence of microbiological factors on mortality, including BSI-causative microorganisms and their major antimicrobial resistance, was emphasized in both periods of days 8–30 and after Day 30.</p></div>","PeriodicalId":56117,"journal":{"name":"Journal of Microbiology Immunology and Infection","volume":"57 1","pages":"Pages 97-106"},"PeriodicalIF":4.5000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1684118223002141/pdfft?md5=a166874508aa9f03ebbc12d4798e5ebf&pid=1-s2.0-S1684118223002141-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Shift in risk factors for mortality by period of the bloodstream infection timeline\",\"authors\":\"Min Hyuk Choi , Dokyun Kim , Jihyun Kim , Young Goo Song , Seok Hoon Jeong\",\"doi\":\"10.1016/j.jmii.2023.11.008\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>This study was designed to determine changes in risk factors on the prognosis of patients during each period of the bloodstream infection (BSI) timeline.</p></div><div><h3>Methods</h3><p>Through an integrated study of multivariable regressions with machine learning techniques, the risk factors for mortality during each period of BSI were analyzed.</p></div><div><h3>Results</h3><p>A total of 302,303 inpatients who underwent blood cultures during 2011–2021 were enrolled. More than 8 % of BSI cases progressed to subsequent BSI, and risk factors were identified as gut colonization with vancomycin-resistant enterococci (aOR 1.82; 95 % CI 1.47–2.24), intensive care unit admission (aOR 3.37; 95 % CI 3.35–4.28), and current cancer chemotherapy (aOR 1.54; 95 % CI 1.36–1.74). The mean SOFA score of the deceased patients during the first 7 days was 10.6 (SD 4.3), which was significantly higher than those on days 8–30 (7.0 ± 4.2) and after Day 30 (4.0 ± 3.5). BSIs caused by <em>Acinetobacter baumannii</em> and <em>Candida albicans</em> were more likely to result in deaths of patients for all time periods (all, <em>P</em> < 0.001). BSIs caused by <em>Enterococcus faecalis</em> and <em>Enterococcus faecium</em> were associated with a poor outcome in the period after Day 30 (both, <em>P</em> < 0.001). Nonsusceptible phenotypes to β-lactam/β-lactamase inhibitors of <em>Escherichia coli</em> and <em>Klebsiella pneumoniae</em> influenced the prognoses of patients with BSI in terms of high mortality rates during both days 8–30 and after Day 30.</p></div><div><h3>Conclusion</h3><p>Influence of microbiological factors on mortality, including BSI-causative microorganisms and their major antimicrobial resistance, was emphasized in both periods of days 8–30 and after Day 30.</p></div>\",\"PeriodicalId\":56117,\"journal\":{\"name\":\"Journal of Microbiology Immunology and Infection\",\"volume\":\"57 1\",\"pages\":\"Pages 97-106\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2024-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S1684118223002141/pdfft?md5=a166874508aa9f03ebbc12d4798e5ebf&pid=1-s2.0-S1684118223002141-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Microbiology Immunology and Infection\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1684118223002141\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Microbiology Immunology and Infection","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1684118223002141","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
Shift in risk factors for mortality by period of the bloodstream infection timeline
Background
This study was designed to determine changes in risk factors on the prognosis of patients during each period of the bloodstream infection (BSI) timeline.
Methods
Through an integrated study of multivariable regressions with machine learning techniques, the risk factors for mortality during each period of BSI were analyzed.
Results
A total of 302,303 inpatients who underwent blood cultures during 2011–2021 were enrolled. More than 8 % of BSI cases progressed to subsequent BSI, and risk factors were identified as gut colonization with vancomycin-resistant enterococci (aOR 1.82; 95 % CI 1.47–2.24), intensive care unit admission (aOR 3.37; 95 % CI 3.35–4.28), and current cancer chemotherapy (aOR 1.54; 95 % CI 1.36–1.74). The mean SOFA score of the deceased patients during the first 7 days was 10.6 (SD 4.3), which was significantly higher than those on days 8–30 (7.0 ± 4.2) and after Day 30 (4.0 ± 3.5). BSIs caused by Acinetobacter baumannii and Candida albicans were more likely to result in deaths of patients for all time periods (all, P < 0.001). BSIs caused by Enterococcus faecalis and Enterococcus faecium were associated with a poor outcome in the period after Day 30 (both, P < 0.001). Nonsusceptible phenotypes to β-lactam/β-lactamase inhibitors of Escherichia coli and Klebsiella pneumoniae influenced the prognoses of patients with BSI in terms of high mortality rates during both days 8–30 and after Day 30.
Conclusion
Influence of microbiological factors on mortality, including BSI-causative microorganisms and their major antimicrobial resistance, was emphasized in both periods of days 8–30 and after Day 30.
期刊介绍:
Journal of Microbiology Immunology and Infection is an open access journal, committed to disseminating information on the latest trends and advances in microbiology, immunology, infectious diseases and parasitology. Article types considered include perspectives, review articles, original articles, brief reports and correspondence.
With the aim of promoting effective and accurate scientific information, an expert panel of referees constitutes the backbone of the peer-review process in evaluating the quality and content of manuscripts submitted for publication.